DE69625373T2 - Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs - Google Patents

Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs

Info

Publication number
DE69625373T2
DE69625373T2 DE69625373T DE69625373T DE69625373T2 DE 69625373 T2 DE69625373 T2 DE 69625373T2 DE 69625373 T DE69625373 T DE 69625373T DE 69625373 T DE69625373 T DE 69625373T DE 69625373 T2 DE69625373 T2 DE 69625373T2
Authority
DE
Germany
Prior art keywords
temozolomide
combination
alpha interferon
advanced cancer
treating advanced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625373T
Other languages
English (en)
Other versions
DE69625373D1 (de
Inventor
H Dugan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69625373D1 publication Critical patent/DE69625373D1/de
Publication of DE69625373T2 publication Critical patent/DE69625373T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69625373T 1995-10-04 1996-10-01 Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs Expired - Lifetime DE69625373T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US623395P 1995-10-04 1995-10-04
US62541096A 1996-03-27 1996-03-27
PCT/US1996/015413 WO1997012630A1 (en) 1995-10-04 1996-10-01 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer

Publications (2)

Publication Number Publication Date
DE69625373D1 DE69625373D1 (de) 2003-01-23
DE69625373T2 true DE69625373T2 (de) 2003-05-15

Family

ID=26675350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625373T Expired - Lifetime DE69625373T2 (de) 1995-10-04 1996-10-01 Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs

Country Status (10)

Country Link
EP (1) EP0859630B1 (de)
JP (2) JP4156028B2 (de)
AT (1) ATE229343T1 (de)
AU (1) AU719074B2 (de)
CA (1) CA2233544A1 (de)
DE (1) DE69625373T2 (de)
DK (1) DK0859630T3 (de)
ES (1) ES2183977T3 (de)
PT (1) PT859630E (de)
WO (1) WO1997012630A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165071B1 (de) * 1999-03-30 2005-11-23 Schering Corporation Verbesserte krebsbehandlung mit temozolomid
MXPA02007172A (es) * 2000-01-24 2002-12-13 Schering Corp Combinacion de temozolomida y alfa interferon pegilado para tratamiento de cancer.
EP1908477A3 (de) * 2000-01-24 2008-06-11 Schering Corporation Kombination aus Temozolomid und pegyliertem Interferon-alpha zur Krebsbehandlung
EP1909822B1 (de) 2005-06-29 2013-09-25 Yeda Research And Development Co., Ltd. Rekombinante interferon alpha 2 (ifn alpha 2) mutanten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
ES2058555T3 (es) * 1988-12-01 1994-11-01 Schering Corp Medicamento para el tratamiento intralesional del carcinoma de celulas escamosas, con alfa-interferon humano recombinante.
AU651998B2 (en) * 1990-10-12 1994-08-11 F. Hoffmann-La Roche Ag Use of a retinoid
DE4244548C2 (de) * 1992-12-30 1997-10-02 Stockhausen Chem Fab Gmbh Pulverförmige, unter Belastung wäßrige Flüssigkeiten sowie Blut absorbierende Polymere, Verfahren zu ihrer Herstellung und ihre Verwendung in textilen Konstruktionen für die Körperhygiene

Also Published As

Publication number Publication date
ES2183977T3 (es) 2003-04-01
EP0859630B1 (de) 2002-12-11
AU719074B2 (en) 2000-05-04
CA2233544A1 (en) 1997-04-10
DK0859630T3 (da) 2003-03-24
ATE229343T1 (de) 2002-12-15
JPH11514995A (ja) 1999-12-21
JP2007169300A (ja) 2007-07-05
WO1997012630A1 (en) 1997-04-10
JP4156028B2 (ja) 2008-09-24
AU7373196A (en) 1997-04-28
EP0859630A1 (de) 1998-08-26
DE69625373D1 (de) 2003-01-23
PT859630E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
DE69617469D1 (de) Behandlung von multipler sklerose
DE69426690D1 (de) Behandlung von atrophischer Haut und Vagina
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69713620D1 (de) Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia
DE69512760D1 (de) Verwendung von Melatonin zur Behandlung von Patienten die an Drogenabhängigkeit leiden
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69625373D1 (de) Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DK0858341T3 (da) Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin
DE68909750T2 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
DE69732851D1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
SE9003140D0 (sv) Method and composition for treatment of heart diseases
DE3778900D1 (de) Arzneimittel fuer die prophylaxe und die behandlung von leberkrankheiten.
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
ATE95414T1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
DE69005837D1 (de) Verwendung bestimmter gamma-Interferone zur Behandlung von Krebs des Ovars.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition